MEDIA COVERAGE
- July 13, 2022Practical Neurology: Phase 3 Trial for Buntanetap for Parkinson Disease Initiated
- July 12, 2022Parkinson's News Today: FDA Gives Green Light to Phase 3 Trial of Buntanetap
- July 08, 2022Clinical Trials Arena: Annovis Bio receives FDA notice to advance Phase III Parkinson’s trial
- July 07, 2022BioSpace: Intercept, Annovis and Biohaven Advance Late Phase Trials
- July 07, 2022BioTuesdays: Annovis Bio gets FDA okay for Phase 3 Parkinson’s trial
- June 27, 2022DocWire News: Dr. Maria Maccecchini, CEO, Annovis Bio: Developing Novel Treatments for Neurodegenerative Disorders
- May 19, 2022TechNation Radio Podcast: Episode 22-21 What’s Up with Netflix? on Apple Podcasts
- March 11, 2022Biotech IQ Podcast: Is axonal transport the key to solving neurodegenerative diseases? Maria Maccechini, PhD - CEO, Annovis Bio
- February 24, 2022Alzhemier's Speaks Radio: Annovis, a Biotech Company, Shares Updates on Their Research
- February 04, 2022Finding Genius Podcast: Understanding Neurodegenerative Diseases and the Links Between Parkinson"s and Alzheimer"s Disease with Dr. Cheng Fang
- February 02, 2022Pharmaceutical Executive: Ready for Pharma’s Next Chapter
- January 19, 2022Healthbiz Podcast: CNS drug development roundtable with Annovis and Clene
- January 07, 2022CFO Dive: Annovis Bio CFO looks to shelf registration, big pharma for capital runway
- December 27, 2021Parkinson's News Today: Planned Phase 3 Trials of Oral Buntanetap to Span Disease Stages
- December 23, 2021Practical Neurology: Posiphen Treatment Provides Clinical Improvement of Alzheimer and Parkinson Disease in Clinical Trials
- December 14, 2021BioTuesdays: Annovis Bio improving information highway of nerve cells to treat AD, PD
- December 06, 2021Health Professional Radio: Annovis Bio – Lead Program to Treat Alzheimer’s and Parkinson’s Diseases
- November 22, 2021Clinical Trial Arena: Annovis reveals blueprint for Phase III Alzheimer’s, Parkinson’s disease trials
- October 08, 2021Neurology Live: ANVS401 Demonstrates Safety, Improves Parkinson Disease Motor Function
Back to Top